Drug Trial Radar · NCT03041805
Caprini Score in Venous Surgery: a Prospective Cohort Study
Last checked: Nov 20, 2026Latest source record: Mar 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
3,000
Planned (sponsor's estimate)
Start
Jan 1, 2017
Primary completion
Jan 1, 2027
Study completion Jan 1, 2027
Sponsor
- Lead sponsor
- Pirogov Russian National Research Medical UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 3, 2017
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study is to make a validation of Caprini score in patients undergoing varicose veins surgery, especially endovascular procedures (endovascular laser treatment - EVLT, radiofrequency ablation - RFA, ultrasound-guided foam sclerotherapy - USFS) and to identify patients with elevated risk of postoperative venous thromboembolism (VTE) who will benefit from prophylactic anticoagulation.
Conditions
- Venous Thromboembolism
- Varicose Veins
Interventions
EVLTProcedure
Endovenous laser treatment of great saphenous vein, small saphenous vein, accessorial saphenous vein with different laser wavelength and any bare type
RFAProcedure
Radiofrequency ablation of great saphenous vein, small saphenous vein, accessorial saphenous vein with ClosureFast technique
USFSProcedure
Ultrasound guided foam sclerotherapy of great saphenous vein, small saphenous vein, accessorial saphenous vein with polidocanol or tetradecyl sulphate of any concentration
HL/strippingProcedure
High ligation and stripping of great saphenous vein, small saphenous vein, accessorial saphenous vein
MiniphlebectomyProcedure
Miniphlebectomy of any varicose veins under local, regional or general anaesthesia
SclerotherapyProcedure
Foam or liquid sclerotherapy of any varicose veins with polidocanol or tetradecyl sulphate of any concentration
GCSDevice
Graduated compression stockings may be used after procedure by the decision of the doctor
LMWHDrug
Low-molecular-weight heparin may be used after procedure by the decision of the doctor
Primary outcomes
What the sponsor says the trial is designed to measure.
- any episode of VTETime frame: 0-4 weeks after procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Pirogov Russian National Research Medical University
Moscow, Russia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.